logo
Share SHARE
FONT-SIZE Plus   Neg

Life Tech To Collaborate With Merck Serono For Diagnostics Development

Life Technologies Corp. (LIFE: Quote) announced that it has signed an agreement to collaborate with Merck Serono, a division of German drugmaker Merck KGaA (MKGAY.PK), for current and future companion diagnostics projects. The current agreement constitutes the first collaboration between the two companies and represents another step in Life Technologies' strategy to develop its diagnostic business through internal development, collaborations and select acquisitions.

The non-exclusive agreement covers an initial project for oncology and provides for a long-term collaboration across a potentially broad range of Life instrument platforms and a wide range of therapeutic areas. Financial terms of the agreement were not disclosed.

According to the Life Technologies, the collaboration will seek to combine the biomarkers identified by Merck's translational research with Life Technologies' proprietary platform technologies and to develop companion diagnostics concurrently with Merck's drug development programs. The collaboration will also work to simultaneously seek regulatory approval of Merck's drug and Life Technologies' companion diagnostic.

Life Technologies said it offers a variety of platform technologies that support the development of new diagnostics. These technologies span both genetic and proteomic analysis, including next-generation sequencing, Sanger sequencing, qPCR and flow cytometry, some of which have already received clearance by the Food and Drug Administration (FDA). If successful, the agreement will be followed by a commercialization agreement under which Life Technologies will commercialize the companion diagnostic in agreed upon territories.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Israeli generic drug maker Teva Pharmaceutical Industries (TEVA) on Tuesday offered to buy smaller Dutch rival Mylan N.V. (MYL) for $82 per share in cash and stock, or about $40 billion, in a bid to further tighten its grip in the global generic space. Twitter is expanding its direct messaging feature to enable users to communicate privately with a single person or with a group of people, even if they are not following each other. High-flying Netflix may have yet another hit on its hands, as the company has ordered a spin-off of the hugely popular Full House series. Fuller House will star Candace Cameron-Bure, Jodie Sweetin and Andrea Barber, who played sisters D.J. Tanner and Stephanie Tanner, and D.J.'s bestie Kimmy Gibbler,...
comments powered by Disqus
Follow RTT